PURA - Puration Targets Acquisition in $6.9 Billion CBD Gummies Market
February 06 2020 - 03:15PM
InvestorsHub NewsWire
Dallas, TX -- February 6, 2020 -- InvestorsHub NewsWire
-- Puration, Inc. (OTC
Pink: PURA) management today indicated plans to make a formal
offer next week to acquire a CBD Infused Confections operation
currently producing CBD Infused Gummies and CBD Infused Gum. The
CBD Infused Gummies market alone is anticipated to
reach $6.9 Billion by 2025. PURA
recently announced plans to pursue the acquisition of operations
producing cannabis infused beverages, edibles and topicals. PURA
management anticipates securing a $5 million investment to fund
acquisitions based on a recent term sheet. The proposed investment
terms outline an up to $5 million debt facility whereby funds would
be drawn as needed to fund acquisitions. The drawn funds would be
secured by the acquired asset and the debt could be repaid in stock
at $0.10 per share. PURA management anticipates closing on the $5
million investment soon with an announcement as early as Monday
next week. The formal acquisition of the CBD Infused Confections
operation is anticipated to follow promptly thereafter.
For more information on Puration, visit http://www.purationinc.com.
Disclaimer/Safe Harbor:
This news release contains forward-looking statements within the
meaning of the Securities Litigation Reform Act. The statements
reflect the Company's current views with respect to future events
that involve risks and uncertainties. Among others, these risks
include the expectation that any of the companies mentioned herein
will achieve significant sales, the failure to meet schedule or
performance requirements of the companies' contracts, the
companies' liquidity position, the companies' ability to obtain new
contracts, the emergence of competitors with greater financial
resources and the impact of competitive pricing. In the light of
these uncertainties, the forward-looking events referred to in this
release might not occur. These statements have not been evaluated
by the Food and Drug Administration. These products are not
intended to diagnose, treat, cure, or prevent any disease.
Contact:
Puration, Inc.
Brian Shibley
info@aciconglomerated.com
+1-(800)-861-1350
Puration (CE) (USOTC:PURA)
Historical Stock Chart
From Feb 2024 to Mar 2024
Puration (CE) (USOTC:PURA)
Historical Stock Chart
From Mar 2023 to Mar 2024